Medical Devices

ICU Medical Receives FDA Clearance for Plum Solo™ and Plum Duo™ Precision IV Pumps in the U.S.

New Infusion Devices Enhance Accuracy and Expand ICU Medical's IV Performance Platform...

Exactech Unveils Next Generation of Predict+® for Enhanced Shoulder Replacement Outcomes – U.S.

Advanced Machine Learning Tool Integrates with Shoulder Planning App to Personalize Surgical Predictions...

Accuray CyberKnife® Featured in U.S. Studies Highlighting CNS Tumor Treatment Benefits

Research Presented at Radiosurgery Society Meeting Showcases Precision and Clinical Advantages ...

AliveDx Submits FDA 510(k) for MosaiQ AiPlex® CTDplus Multiplex Microarray in the U.S.

Advanced Diagnostic Technology Aims to Enhance Detection of Connective Tissue Diseases ...

MedRhythms Launches Movive™ for Parkinson’s Treatment in U.S. Veterans’ Healthcare

Digital Therapeutic Enhances Mobility and Quality of Life for PD Patients...

Large, randomized control trial of a novel angioplasty device, conducted on a broadly representative population, demonstrated positive results over a contemporary drug-eluting stent

• One-third of all deaths in Singapore are caused by cardiovascular disease (CVD), with stroke, and myocardial infarction (MI) being the leading causes of death, driving the need for percutaneous coronary intervention (PCI) • Building upon the results of the BIOADAPTOR RCT (randomized clinical trial), the 12- month data from the INFINITY-SWEDEHEART trial further validates the DynamX® Coronary Bioadaptor System’s unique mechanism of action in complex PCI population subsets • The 12 months’ ...

Peijia Medical & dsm-firmenich Partner in China to Develop Innovative Medical Devices

Collaboration Aims to Advance Cutting-Edge Solutions for Improved Patient Care...

Medical Guardian Expands Remote Monitoring in the U.S. to Enhance Chronic Disease Management

Advanced Telehealth Solutions Aim to Reduce Hospital Readmissions and Improve Patient Care...